Imunon (IMNN) Income towards Parent Company (2010 - 2026)

Imunon (IMNN) has 17 years of Income towards Parent Company data on file, last reported at -$4.4 million in Q1 2026.

• Quarterly Income towards Parent Company fell 2.41% year-over-year to -$4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$16.4 million (up 12.87% YoY) and the FY2025 annual result came in at -$91.3 million, down 390.19% from the prior year.
• Income towards Parent Company eased to -$4.4 million in Q1 2026, from -$4.3 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of -$3.6 million in Q3 2025 to a low of -$11.1 million in Q4 2022.
• A 5-year average of -$5.3 million and a median of -$5.2 million in 2024 frame the typical range for Income towards Parent Company.
• Annual changes were most pronounced in 2022 — Income towards Parent Company slumped 170.67% — and 2023, when it jumped 45.38%.
• Tracing IMNN's Income towards Parent Company over 5 years: stood at -$11.1 million in 2022, then jumped by 45.38% to -$6.0 million in 2023, then surged by 30.65% to -$4.2 million in 2024, then slipped by 3.47% to -$4.3 million in 2025, then slipped by 0.67% to -$4.4 million in 2026.
• The last three Income towards Parent Company figures came in at -$4.4 million (Q1 2026), -$4.3 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.